These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 22559254)

  • 1. Haplotype-based banking of human pluripotent stem cells for transplantation: potential and limitations.
    Zimmermann A; Preynat-Seauve O; Tiercy JM; Krause KH; Villard J
    Stem Cells Dev; 2012 Sep; 21(13):2364-73. PubMed ID: 22559254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generating an iPSC bank for HLA-matched tissue transplantation based on known donor and recipient HLA types.
    Taylor CJ; Peacock S; Chaudhry AN; Bradley JA; Bolton EM
    Cell Stem Cell; 2012 Aug; 11(2):147-52. PubMed ID: 22862941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of human leukocyte antigen matching in the development of multiethnic "haplobank" of induced pluripotent stem cell lines.
    Gourraud PA; Gilson L; Girard M; Peschanski M
    Stem Cells; 2012 Feb; 30(2):180-6. PubMed ID: 22045598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of HLA Homozygous Cord Blood Transplantation: Implications for Induced Pluripotent Stem Cell Banking and Transplantation.
    Morishima Y; Azuma F; Kashiwase K; Matsumoto K; Orihara T; Yabe H; Kato S; Kato K; Kai S; Mori T; Nakajima K; Morishima S; Satake M; Takanashi M; Yabe T;
    Stem Cells Transl Med; 2018 Feb; 7(2):173-179. PubMed ID: 29274116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haplobanking induced pluripotent stem cells for clinical use.
    Sullivan S; Fairchild PJ; Marsh SGE; Müller CR; Turner ML; Song J; Turner D
    Stem Cell Res; 2020 Dec; 49():102035. PubMed ID: 33221677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repurposing the Cord Blood Bank for Haplobanking of HLA-Homozygous iPSCs and Their Usefulness to Multiple Populations.
    Lee S; Huh JY; Turner DM; Lee S; Robinson J; Stein JE; Shim SH; Hong CP; Kang MS; Nakagawa M; Kaneko S; Nakanishi M; Rao MS; Kurtz A; Stacey GN; Marsh SGE; Turner ML; Song J
    Stem Cells; 2018 Oct; 36(10):1552-1566. PubMed ID: 30004605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proceedings: human leukocyte antigen haplo-homozygous induced pluripotent stem cell haplobank modeled after the california population: evaluating matching in a multiethnic and admixed population.
    Pappas DJ; Gourraud PA; Le Gall C; Laurent J; Trounson A; DeWitt N; Talib S
    Stem Cells Transl Med; 2015 May; 4(5):413-8. PubMed ID: 25926330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of 28 human embryonic stem cell lines for use as unrelated donors in stem cell therapy: implications of HLA and ABO genotypes.
    Lee JE; Kang MS; Park MH; Shim SH; Yoon TK; Chung HM; Lee DR
    Cell Transplant; 2010; 19(11):1383-95. PubMed ID: 20587141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High resolution HLA class I and II typing and CTLp frequency in unrelated donor transplantation: a single-institution retrospective study of 69 BMTs.
    El Kassar N; Legouvello S; Joseph CM; Salesses P; Rieux C; Cordonnier C; Vernant JP; Farcet JP; Bierling P; Kuentz M
    Bone Marrow Transplant; 2001 Jan; 27(1):35-43. PubMed ID: 11244436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA-based banking of induced pluripotent stem cells in Saudi Arabia.
    Alowaysi M; Lehmann R; Al-Shehri M; Baadhaim M; Alzahrani H; Aboalola D; Zia A; Malibari D; Daghestani M; Alghamdi K; Haneef A; Jawdat D; Hakami F; Gomez-Cabrero D; Tegner J; Alsayegh K
    Stem Cell Res Ther; 2023 Dec; 14(1):374. PubMed ID: 38111036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human leukocyte antigen and adult living-donor liver transplantation outcomes: an analysis of the organ procurement and transplantation network database.
    Jakab SS; Navarro VJ; Colombe BW; Daskalakis C; Herrine SK; Rossi S
    Liver Transpl; 2007 Oct; 13(10):1405-13. PubMed ID: 17902126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential and limitation of HLA-based banking of human pluripotent stem cells for cell therapy.
    de Rham C; Villard J
    J Immunol Res; 2014; 2014():518135. PubMed ID: 25126584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Retinal regeneration with iPS cells ‒ Clinical trials for retinal degenerative disorders].
    Sugita S
    Nihon Rinsho Meneki Gakkai Kaishi; 2015; 38(2):79-85. PubMed ID: 26016634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The safety of human pluripotent stem cells in clinical treatment.
    Simonson OE; Domogatskaya A; Volchkov P; Rodin S
    Ann Med; 2015; 47(5):370-80. PubMed ID: 26140342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA-C matching and liver transplants: donor-recipient genotypes influence early outcome and CD8+KIR2D+ T-cells recuperation.
    López-Alvarez MR; Moya-Quiles MR; Minguela A; Gil J; Miras M; Campillo JA; Díaz-Alderete MA; García-Alonso AM; Sánchez-Bueno F; Vicario JL; Muro M; Alvarez-López MR
    Transplantation; 2009 Aug; 88(3 Suppl):S54-61. PubMed ID: 19667963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological considerations for embryonic and induced pluripotent stem cell banking.
    Taylor CJ; Bolton EM; Bradley JA
    Philos Trans R Soc Lond B Biol Sci; 2011 Aug; 366(1575):2312-22. PubMed ID: 21727137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of HLA in hematopoietic SCT.
    Nowak J
    Bone Marrow Transplant; 2008 Oct; 42 Suppl 2():S71-6. PubMed ID: 18978750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human leukocyte antigen matching estimations in a hypothetical bank of human embryonic stem cell lines in the Japanese population for use in cell transplantation therapy.
    Nakajima F; Tokunaga K; Nakatsuji N
    Stem Cells; 2007 Apr; 25(4):983-5. PubMed ID: 17185611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Living-donor liver transplantation at the University of Tokyo, 1996-2011: the impact of HLA matching and a positive crossmatch on long-term survival and tolerance.
    Waki K; Sugawara Y; Mizuta K; Fujita H; Kadowaki T; Kokudo N
    Clin Transpl; 2011; ():223-35. PubMed ID: 22755416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Selection of an unrelated donor for hematopoietic stem cell transplantation. HLA haplotypes in patients with blood system diseases].
    Khamaganova EG; Parovichnikova EN; Kuz'mina LA; Gemdzhian ÉG; Chugreeva TP; Iushkova AA
    Ter Arkh; 2014; 86(7):31-6. PubMed ID: 25314775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.